Verizon: 'Cybersecurity and network transformation. So, in the cybersecurity space, we know from our very deep research that ...
BCW is one of the first Web3 focused Google Cloud Partners in APAC that has achieved the Generative AI Partner Specialization. BCW is one o ...
APAC (39%) and Europe (36%) accounted for the majority of activity ... Phishing was the most common initial access vector in 2024, even as newer TTPs emerged. The number of deepfake services ...
Oxford Nanopore Technologies plc ( OTCPK:ONTTF) Q4 2024 Results Conference Call March 4, 2025 4:30 AM ET Gordon Sanghera - Chief Executive Officer Nick Keher - Chief Financial Officer ...
Uganda’s malaria burden is staggering, with some areas such as Apac District recording the ... Dr Lugemwa says an invasive mosquito vector, Anopheles stephensi, has come into play.
Elastic’s chief product officer Ken Exner talks up the company’s expansion into observability and security and how it ...
The APAC private wealth management landscape is shifting rapidly as new tools and client demands push the industry toward increased efficiency, accuracy, and competition. Recent discussions and ...
This expansion reflects Options’ ongoing commitment to supporting clients and partners in the Asia-Pacific (APAC) region and reinforces its ability to deliver cutting-edge solutions tailored to ...
cyber security has become more multi-dimensional and varied across specialisations, organisations and industries. In this e-guide, learn what it takes to become a successful cyber security pro in ...
Cancer Gene Therapy Market to Soar to US$ 17.57 Billion by 2033, Registering a Robust CAGR of 18.24%
The global Cancer Gene Therapy Market was valued at US$ 3.89 billion in 2024 and is projected to experience a remarkable surge to US$ 17.57 billion by 2033, growing at a compelling CAGR of 18.24% ...
According to Josh Doolan, Mudbath’s founder and now managing director of Endava APAC, the acquisition was a game-changer for both companies. “My career started in the aftermath of the dotcom ...
Viatris will be the exclusive owner of cenerimod rights in Japan and APAC (ex-China). Viatris gained exclusive rights to cenerimod in all other territories from Idorsia through a research and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results